KEY vs OGEN · P/E 13, rev $7.51B vs rev $37.7K
KeyCorp (KEY) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the KEY and OGEN stock pages for the full models.
Not investment advice.